Press Release Summary:
Eliminating need for cleaning and autoclaving, FibraStage(TM) disposable cell culture system produces high yields of protein, virus, or cell mass from anchorage-dependent or suspension cultures. Console base accommodates up to four 500 ml disposable culture vessels pre-filled with FibraCelÂ® disks. In addition to virus and vaccine production, applications include gene therapy/drug discovery, human proteome and cell therapy, and tissue engineering.
Original Press Release:
New Brunswick Scientific Co., Inc., Launches New Low-Cost, High-Yield FibraStage(TM) Disposable Cell Culture System
EDISON, N.J., Oct. 3 -- New Brunswick Scientific Co., Inc. (NBS) (NASDAQ:NBSC), today announced the roll-out of FibraStage(TM), a new disposable cell culture system in the Company's extensive range of equipment for culture growth, detection and storage.
According to New Brunswick Scientific President and Chief Operating Officer James Orcutt, the FibraStage system provides all of the advantages of existing pre-sterilized, single-use cell culture systems -- eliminating the need for cleaning and autoclaving -- while at the same time offering reduced operating cost, compact size and high yields of protein, virus or cell mass from anchorage-dependent or suspension cultures.
Orcutt explained, "At the heart of the FibraStage system is a console base that accommodates up to four 500 ml disposable culture vessels pre-filled with patented FibraCel(R) disks. FibraCel is a solid-support matrix designed to provide an increased surface area for cell growth, resulting in higher cell densities. A single FibraStage system can eliminate the need to maintain numerous spinner flasks, dozens of roller bottles and hundreds of T-flasks."
"Thus far in 2005, we have launched several innovative new products including two biological shakers and the FibraStage system. We look forward to the roll-out of additional products and product enhancements during the year's final quarter and continuing throughout 2006," Orcutt concluded.
Applications for the FibraStage cell culture system include virus and vaccine production, gene therapy/drug discovery, human proteome, and cell therapy and tissue engineering.
About New Brunswick Scientific
New Brunswick Scientific Co., Inc., is a leading global provider of a comprehensive line of research equipment and scientific instrumentation for use in the life science industry. The Company's products are used in the creation, maintenance and control of physical and biochemical environments required for the growth, detection and storage of microorganisms for medical, biological and chemical applications, as well as environmental research and commercial product development. NBS is a forerunner in the research and development of pioneering equipment to meet the challenges of new areas of advancement in life science. Established in 1946, New Brunswick Scientific is headquartered in Edison, New Jersey, with sales and distribution facilities strategically located in the United States, Europe and Asia. For more information, please visit www.nbsc.com/ .